01st week of 2020 patent applcation highlights part 8 |
Patent application number | Title | Published |
20200000702 | SATIN LIP COMPOSITIONS | 2020-01-02 |
20200000703 | MASCARA COMPOSITIONS COMPRISING A POLYMER HAVING CYCLIC AMIDE, CYCLIC AMINE AND ACRYLAMIDE FUNCTIONALITY | 2020-01-02 |
20200000704 | DEGRADATION INHIBITOR OF HYALURONIC ACID, COMPRISING ROSEMARY EXTRACT AND RETINOL ACETATE | 2020-01-02 |
20200000705 | Aloe smooth skin after shave baume-bump less | 2020-01-02 |
20200000706 | PARENTERAL SUSTAINED-RELEASE DELIVERY OF CARVEDILOL DISPERSE SYSTEMS | 2020-01-02 |
20200000707 | Oral Therapeutic Compound Delivery System | 2020-01-02 |
20200000708 | DISPENSING METHOD FOR PRODUCING DISSOLVABLE UNIT DOSE FILM CONSTRUCTS | 2020-01-02 |
20200000709 | COMBINATION OF BIOELECTRICAL STIMULATOR AND PLATELET-RICH FIBRIN FOR ACCELERATED HEALING AND REGENERATION | 2020-01-02 |
20200000710 | Systems Methods Devices Apparatuses Circuits and Computer Executable Code for Production and Topical Application of a Therapeutic Substance | 2020-01-02 |
20200000711 | COMPOSITIONS AND METHODS TO PROMOTE WOUND HEALING | 2020-01-02 |
20200000712 | METHOD OF RAPIDLY ACHIEVING THERAPEUTIC CONCENTRATIONS OF TRIPTANS FOR TREATMENT OF MIGRAINES AND CLUSTER HEADACHES | 2020-01-02 |
20200000713 | INJECTABLE POLYMER MICRO-DEPOTS FOR CONTROLLED LOCAL DRUG DELIVERY | 2020-01-02 |
20200000714 | OPHTHALMIC COMPOSITION COMPRISING PVP-I | 2020-01-02 |
20200000715 | NASOLACRIMAL DRAINAGE SYSTEM IMPLANTS FOR DRUG THERAPY | 2020-01-02 |
20200000716 | MULTICOMPONENT GUMMY COMPOSITIONS WITH HARD CORE | 2020-01-02 |
20200000717 | FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM | 2020-01-02 |
20200000718 | Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds | 2020-01-02 |
20200000719 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | 2020-01-02 |
20200000720 | ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS | 2020-01-02 |
20200000721 | AQUEOUS COMPOSITIONS AND ASSOCIATED CREAM FORMULATIONS | 2020-01-02 |
20200000722 | SYNTHETIC POLYPEPTIDES AND USES THEREOF | 2020-01-02 |
20200000723 | BIODEGRADABLE COMPOUND, LIPID PARTICLES, COMPOSITION AND KIT COMPRISING LIPID PARTICLES | 2020-01-02 |
20200000724 | PROCESS FOR PRODUCING A NANO-CBD LIPOSOME SYSTEM | 2020-01-02 |
20200000725 | Antibiotic Beads for Treatment of an Infection | 2020-01-02 |
20200000726 | GASTRORESISTANT PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN | 2020-01-02 |
20200000727 | OXIDIZED CELLULOSE MICROSPHERES | 2020-01-02 |
20200000728 | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | 2020-01-02 |
20200000729 | ERYTHRITOL GRANULES AND METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING TABLETS USING SAME, AND TABLETS | 2020-01-02 |
20200000730 | SOLID PREPARATION | 2020-01-02 |
20200000731 | EXTENDED RELEASE PHARMACEUTICAL FORMULATION | 2020-01-02 |
20200000732 | PROBIOTIC COMPOSITIONS AND DOSAGE FORMS, AND METHODS FOR PREPARING AND USING THE SAME | 2020-01-02 |
20200000733 | COMPOSITION FOR CONTROLLED RELEASE OF PHYSIOLOGICALLY ACTIVE SUBSTANCES AND PROCESS FOR ITS PREPARATION | 2020-01-02 |
20200000734 | AGGREGATING MICROPARTICLES FOR MEDICAL THERAPY | 2020-01-02 |
20200000735 | AGGREGATING MICROPARTICLES FOR MEDICAL THERAPY | 2020-01-02 |
20200000736 | OIL-FREE CAROTENOID COMPOSITION | 2020-01-02 |
20200000737 | BUTORPHANOL-CONTAINING PATCH | 2020-01-02 |
20200000738 | Base Composition for Tape Agent | 2020-01-02 |
20200000739 | Composition for the Transdermal Delivery of Fentanyl | 2020-01-02 |
20200000740 | ZEAXANTHIN FOR TUMOR TREATMENT | 2020-01-02 |
20200000741 | USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY | 2020-01-02 |
20200000742 | COMBINATION | 2020-01-02 |
20200000743 | TFEB ACTIVATOR C1 AMELIORATES APP AND TAU PATHOLOGY AND RESCUES COGNITIVE DEFICITS IN NEURODEGENERATIVE DISEASES | 2020-01-02 |
20200000744 | PHARMACEUTICAL COMPOSITION | 2020-01-02 |
20200000745 | Chemical medicinal composition used for the improvement of sleep | 2020-01-02 |
20200000746 | TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE | 2020-01-02 |
20200000747 | BINGE BEHAVIOR REGULATORS | 2020-01-02 |
20200000748 | METHOD OF TREATING MAJOR DEPRESSIVE DISORDER | 2020-01-02 |
20200000749 | USE OF SENICAPOC FOR TREATMENT OF STROKE | 2020-01-02 |
20200000750 | Composition for Treating Acute and Chronic Pain | 2020-01-02 |
20200000751 | CARBOXYLIC ACIDS FOR TREATING/PREVENTING NASAL CONGESTION | 2020-01-02 |
20200000752 | Method for Treating Epilepsy | 2020-01-02 |
20200000753 | PHARAMACEUTICAL COMPOSITIONS FOR TREATING CHRONIC PAIN AND PAIN ASSOCIATED WITH NEUROPATHY | 2020-01-02 |
20200000754 | NOVEL VISCOELASTIC SOLUTION AND USE THEREOF IN RHUMATOLOGY | 2020-01-02 |
20200000755 | TREATMENT OF INFLAMMATORY DISORDERS IN NON-HUMAN MAMMALS | 2020-01-02 |
20200000756 | NEOSTIGMINE COMBINATION AND COMPOSITIONS | 2020-01-02 |
20200000757 | METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME | 2020-01-02 |
20200000758 | Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs Thereof | 2020-01-02 |
20200000759 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME | 2020-01-02 |
20200000760 | METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | 2020-01-02 |
20200000761 | Method for preparing medicine with dicaffeoylquinic acid for treating gout | 2020-01-02 |
20200000762 | CYSTEAMINE PRODRUGS | 2020-01-02 |
20200000763 | Low-Dose Doxepin Formulations And Methods Of Making And Using The Same | 2020-01-02 |
20200000764 | Dehydroacetic Acid (DHAA) and Derivative for Uses in Treating Cancer | 2020-01-02 |
20200000765 | TOPICAL COMPOSITIONS COMPRISING POLYOLPREPOLYMERS, STEM CELL, AND CANNABINOIDS FOR SKIN CARE | 2020-01-02 |
20200000766 | COMPOSITIONS AND METHODS FOR AGONIZING THE CB2 RECEPTOR | 2020-01-02 |
20200000767 | LIQUID CANNABINOID COMPOSITION | 2020-01-02 |
20200000768 | Therapeutic Compositions and Uses Thereof | 2020-01-02 |
20200000769 | Medical Uses Of N-(2-Aminoethyl)-N-(4-Benzyloxy)-3-Methoxybenzyl)Thiophene-2-Formamide Hydrochloride | 2020-01-02 |
20200000770 | COMPOUNDS AND METHODS FOR TREATMENT OF PRIMARY BILIARY CHOLANGITIS | 2020-01-02 |
20200000771 | GLUCOCORTICOID RECEPTOR MODULATORS TO TREAT PANCREATIC CANCER | 2020-01-02 |
20200000772 | CENICRIVIROC COMBINATION THERAPY FOR THE TREATMENT OF FIBROSIS | 2020-01-02 |
20200000773 | FAST ACTING ORALLY DISINTEGRATING FILM | 2020-01-02 |
20200000774 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | 2020-01-02 |
20200000775 | ATTENUATION OF NEUROPATHIC PAIN AFTER SPINAL CORD INJURY | 2020-01-02 |
20200000776 | COMBINATION TREATING PROSTATE CANCER, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD | 2020-01-02 |
20200000777 | ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE | 2020-01-02 |
20200000778 | ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE | 2020-01-02 |
20200000779 | THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF | 2020-01-02 |
20200000780 | AZAINDOLES AS INHIBITORS OF HPK1 | 2020-01-02 |
20200000781 | AVIBACTAM AND CARBAPENEMS ANTIBACTERIAL AGENTS | 2020-01-02 |
20200000782 | PHARMACEUTICAL COMPOSITION COMPRISING PYRIDONE DERIVATIVES | 2020-01-02 |
20200000783 | NANOPARTICLES FOR CONTROLLED RELEASE OF SORAFENIB AND SORAFENIB DERIVATIVES | 2020-01-02 |
20200000784 | MATERIALS AND METHODS FOR TREATING VALVULAR HEART DISEASES | 2020-01-02 |
20200000785 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | 2020-01-02 |
20200000786 | PHARMACEUTICAL COMPOSITIONS COMPRISING AN INTEGRIN ALPHA4 ANTAGONIST FOR USE IN TREATING OCULAR INFLAMMATORY CONDITIONS | 2020-01-02 |
20200000787 | MEDICAMENT FOR TREATMENT OF LIVER CANCER | 2020-01-02 |
20200000788 | 5-DEUTERO-2,4-THIAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | 2020-01-02 |
20200000789 | VACUOLE-INDUCING COMPOUNDS, METHODS OF MAKING AND USING THE SAME | 2020-01-02 |
20200000790 | THE COMBINATION OF COTININE PLUS ANTIOXIDANT FOR TREATMENT-RESISTANT DEPRESSION AND CORRECTION OF ASTROCYTES FUNCTIONAL DEFICIT INDUCED BY DEPRESSION AND OTHER NEUROPATHOLOGICAL CONDITIONS | 2020-01-02 |
20200000791 | ORAL PHARMACEUTICAL DOSAGE FORMS | 2020-01-02 |
20200000792 | 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS | 2020-01-02 |
20200000793 | TOPICAL FORMULATIONS OF TARGETED NITROXIDE AGENTS | 2020-01-02 |
20200000794 | BENZOQUINOLONE INHIBITORS OF VMAT2 | 2020-01-02 |
20200000795 | METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS | 2020-01-02 |
20200000796 | METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS | 2020-01-02 |
20200000797 | Multi-Arm Polymeric Targeting Anti-Cancer Conjugate | 2020-01-02 |
20200000798 | PROCESS FOR EXTRACTING THE ALKALOID FRACTION OF RHODOPHIALA BIFIDA (HERB.) TRAUB AND USES THEREOF | 2020-01-02 |
20200000799 | METHOD AND USE OF BUPRENORPHINE IN TREATMENT OF CHRONIC PAIN | 2020-01-02 |
20200000800 | TREATMENT OF JOINT CONDITIONS | 2020-01-02 |
20200000801 | METHODS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS USING VDAC INHIBITORS | 2020-01-02 |